Views | |
---|---|
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema | 175 |
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema | 0 | 0 | 1 | 8 | 2 | 1 | 0 |
Views | |
---|---|
s13601-017-0172-9.pdf | 152 |